226 related articles for article (PubMed ID: 30196181)
1. Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents.
Chung CJ; Kirtane AJ; Zhang Y; Witzenbichler B; Weisz G; Stuckey TD; Brodie BR; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Stone GW
Am Heart J; 2018 Nov; 205():77-86. PubMed ID: 30196181
[TBL] [Abstract][Full Text] [Related]
2. Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.
Giustino G; Redfors B; Kirtane AJ; Mehran R; Dangas GD; Witzenbichler B; Neumann FJ; Weisz G; Généreux P; Maehara A; McAndrew T; Farhan S; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Gurbel P; Ben-Yehuda O; Stone GW
JACC Cardiovasc Interv; 2018 Jul; 11(13):1277-1286. PubMed ID: 29908967
[TBL] [Abstract][Full Text] [Related]
3. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
[TBL] [Abstract][Full Text] [Related]
4. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
5. Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study).
Redfors B; Ben-Yehuda O; Lin SH; Furer A; Kirtane AJ; Witzenbichler B; Weisz G; Stuckey TD; Maehara A; Généreux P; Giustino G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Ayele GM; Mehran R; Mintz GS; Stone GW
Am J Cardiol; 2017 Sep; 120(6):917-923. PubMed ID: 28754568
[TBL] [Abstract][Full Text] [Related]
6. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
[TBL] [Abstract][Full Text] [Related]
7. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
Stone GW; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Gurbel PA; Xu K; Parise H; Kirtane AJ; Brodie BR; Mehran R; Stuckey TD;
Lancet; 2013 Aug; 382(9892):614-23. PubMed ID: 23890998
[TBL] [Abstract][Full Text] [Related]
8. Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation.
Généreux P; Giustino G; Redfors B; Palmerini T; Witzenbichler B; Weisz G; Stuckey TD; Maehara A; Mehran R; Kirtane AJ; Stone GW
Int J Cardiol; 2018 Oct; 268():61-67. PubMed ID: 30041804
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study.
Redfors B; Généreux P; Witzenbichler B; Maehara A; Weisz G; McAndrew T; Mehran R; Kirtane AJ; Stone GW
Am Heart J; 2018 Mar; 197():142-149. PubMed ID: 29447774
[TBL] [Abstract][Full Text] [Related]
10. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).
Kirtane AJ; Parikh PB; Stuckey TD; Xu K; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Parvataneni R; Maehara A; Généreux P; Mehran R; Stone GW
JACC Cardiovasc Interv; 2015 Dec; 8(15):1978-1987. PubMed ID: 26738669
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study).
Faggioni M; Redfors B; Crowley A; Claessen BE; Farhan S; Mastoris I; Witzenbichler B; Maehara A; Weisz G; Généreux P; Ben-Yehuda O; Mehran R; Kirtane AJ; Stone GW
Am J Cardiol; 2020 Mar; 125(5):685-693. PubMed ID: 31926634
[TBL] [Abstract][Full Text] [Related]
12. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
13. Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry.
Mayer K; Bernlochner I; Braun S; Schulz S; Orban M; Morath T; Cala L; Hoppmann P; Schunkert H; Laugwitz KL; Kastrati A; Sibbing D
J Am Coll Cardiol; 2014 Sep; 64(9):863-71. PubMed ID: 25169169
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
15. Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study).
Redfors B; Chen S; Ben-Yehuda O; Huang X; Witzenbichler B; Weisz G; Liu Y; Brodie BR; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Stuckey TD; Kirtane AJ; Stone GW
Am J Cardiol; 2019 Nov; 124(9):1380-1388. PubMed ID: 31477234
[TBL] [Abstract][Full Text] [Related]
16. Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study.
Gupta R; Kirtane AJ; Liu Y; Crowley A; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2019 Nov; 12(11):e007982. PubMed ID: 31672031
[TBL] [Abstract][Full Text] [Related]
17. Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy.
Rubin GA; Kirtane AJ; Chen S; Redfors B; Weisz G; Baber U; Zhang Y; Stuckey TD; Witzenbichler B; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Ali ZA; Ben-Yehuda O; Stone GW
Catheter Cardiovasc Interv; 2020 Oct; 96(4):793-801. PubMed ID: 31721430
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.
Weisz G; Smilowitz NR; Kirtane AJ; Rinaldi MJ; Parvataneni R; Xu K; Stuckey TD; Maehara A; Witzenbichler B; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Stone GW
Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26458411
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous coronary intervention of bifurcation lesions and platelet reactivity.
Redfors B; Généreux P; Witzenbichler B; Kirtane AJ; Maehara A; Weisz G; Madhavan MV; McAndrew T; Mehran R; Stone GW
Int J Cardiol; 2018 Jan; 250():92-97. PubMed ID: 29074039
[TBL] [Abstract][Full Text] [Related]
20. Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy.
Nührenberg TG; Stratz C; Leggewie S; Hochholzer W; Valina CM; Gick M; Kirtane AJ; Stone GW; Neumann FJ; Trenk D
Thromb Haemost; 2015 Nov; 114(5):1020-7. PubMed ID: 26305340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
